Literature DB >> 1419900

Interferon-inducible gene expression in HL-60 cells: effects of the state of differentiation.

S K Bandyopadhyay1, R Kumar, B Y Rubin, G C Sen.   

Abstract

The promyelocytic leukemia line HL-60 can be terminally differentiated in vitro to either monocyte/macrophages or granulocytes. We used this cell line to test whether the state of differentiation of a cell changes its response to interferon (IFN). The characteristics of expression of several IFN-alpha- and IFN-gamma-inducible genes in undifferentiated and differentiated HL-60 cells were examined. p67, an IFN-gamma-inducible protein, was induced similarly in three cell types, whereas another IFN-gamma-inducible protein, p56, was induced strongly only in undifferentiated cells. In contrast, two isozymes of 2,5(A)-synthetase were induced better in differentiated cells in response to either IFN. Several IFN-alpha-inducible mRNAs, e.g., 561, 6-16, 1-8, and 2A, were induced much more strongly in granulocytes than in macrophages or in undifferentiated cells. Electrophoretic mobility shift assays using the IFN-stimulated response element of gene 561 and nuclear extracts of IFN-alpha-treated cells revealed the appearance of one complex and the disappearance of another one, concomitant with differentiation of the cells to granulocytes. These observations suggest that expression of IFN-inducible genes in HL-60 cells is regulated by trans-acting factors whose activity changes with the state of differentiation of the cells. Our study may have implications in the optimal clinical use of IFNs. Inducing cellular differentiation may augment the efficacy of IFNs as antitumor agents.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1419900

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  3 in total

1.  The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines.

Authors:  E Guenzi; K Töpolt; E Cornali; C Lubeseder-Martellato; A Jörg; K Matzen; C Zietz; E Kremmer; F Nappi; M Schwemmle; C Hohenadl; G Barillari; E Tschachler; P Monini; B Ensoli; M Stürzl
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

2.  Tamoxifen enhances interferon-regulated gene expression in breast cancer cells.

Authors:  D J Lindner; V Kolla; D V Kalvakolanu; E C Borden
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

3.  The response of gamma interferon activation factor is under developmental control in cells of the macrophage lineage.

Authors:  A Eilers; D Seegert; C Schindler; M Baccarini; T Decker
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.